- Home
- CLX vs MRNA Comparison
CLX vs MRNA Comparison
Compare CLX & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLX
- MRNA
- Stock Information
- Founded
- CLX 1913
- MRNA 2010
- Country
- CLX United States
- MRNA United States
- Employees
- CLX N/A
- MRNA N/A
- Industry
- CLX Specialty Chemicals
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CLX Consumer Discretionary
- MRNA Health Care
- Exchange
- CLX Nasdaq
- MRNA Nasdaq
- Market Cap
- CLX 19.0B
- MRNA 16.0B
- IPO Year
- CLX N/A
- MRNA 2018
- Fundamental
- Price
- CLX $146.16
- MRNA $31.12
- Analyst Decision
- CLX Hold
- MRNA Hold
- Analyst Count
- CLX 12
- MRNA 20
- Target Price
- CLX $158.17
- MRNA $54.82
- AVG Volume (30 Days)
- CLX 1.6M
- MRNA 9.3M
- Earning Date
- CLX 04-29-2025
- MRNA 05-01-2025
- Dividend Yield
- CLX 3.34%
- MRNA N/A
- EPS Growth
- CLX 478.24
- MRNA N/A
- EPS
- CLX 3.67
- MRNA N/A
- Revenue
- CLX $7,165,000,000.00
- MRNA $3,236,000,000.00
- Revenue This Year
- CLX $1.58
- MRNA N/A
- Revenue Next Year
- CLX $1.26
- MRNA $23.65
- P/E Ratio
- CLX $39.88
- MRNA N/A
- Revenue Growth
- CLX N/A
- MRNA N/A
- 52 Week Low
- CLX $127.60
- MRNA $29.25
- 52 Week High
- CLX $171.37
- MRNA $170.47
- Technical
- Relative Strength Index (RSI)
- CLX 43.84
- MRNA 41.10
- Support Level
- CLX $140.94
- MRNA $31.52
- Resistance Level
- CLX $147.29
- MRNA $34.87
- Average True Range (ATR)
- CLX 2.56
- MRNA 1.83
- MACD
- CLX 0.03
- MRNA -0.17
- Stochastic Oscillator
- CLX 50.77
- MRNA 1.41
Stock Price Comparison Chart: CLX vs MRNA
About CLX Clorox Company (The)
Since its start more than 100 years ago, Clorox has expanded to operate in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just less than 85% of Clorox's sales stem from its home turf.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.